The big news in the diabetes world this week is a new article in the New England Journal of Medicine (link
here) about how Actos (scientific name:
pioglitazone) can help prevent the development of diabetes in folks with prediabetes. The American Diabetes Association has a handy page for helping determine if you have "prediabetes" (link
here). If you're looking at HbA1c, it means that you are between 5.7% and 6.4%.